Login / Signup

Continuous enteral protease inhibition as a novel treatment for experimental trauma/hemorrhagic shock.

Federico AlettiFrank A DeLanoElisa MaffioliHao MuGeert W Schmid-SchönbeinGabriella TedeschiErik B Kistler
Published in: European journal of trauma and emergency surgery : official publication of the European Trauma Society (2021)
Minimally invasive, continuous enteral protease inhibitor delivery improves outcomes in T/HS and is readily translatable to the clinical arena.
Keyphrases
  • minimally invasive
  • robot assisted
  • metabolic syndrome
  • replacement therapy
  • smoking cessation
  • weight loss
  • glycemic control